Navigation Links
Leaders from the National Academies gather to discuss engineering innovations in health care
Date:2/3/2010

WHAT: The National Academy of Engineering (NAE) and the Institute of Medicine (IOM) will join together for the first time at the regional meeting and panel discussion on "Engineering Innovations in Healthcare" at the University of Miami. Hosted by James M. Tien, Ph.D., DEng (h.c.), NAE, Distinguished Professor and Dean of the College of Engineering, and Daniel Berg, PhD, NAE, Distinguished Research Professor of Engineering. A world-renowned group of speakers will convene for an afternoon of intriguing remarks, presentations, and a panel discussion, moderated by University of Miami President Donna E. Shalala.

HOW: The event is free and open to the public but reservations are needed.
Contact Odalis Ruiz, 305-284-6035, odalis@miami.edu

WHEN/WHERE: Thursday, February 25, 2010, at The Storer Auditorium, University of Miami Coral Gables campus, 5250 University Drive.

1:30 PM WELCOMING REMARKS

  • Dr. Daniel Berg, member of NAE and distinguished research professor at the University of Miami College of Engineering. He served as technical director at Westinghouse and former Dean and Provost at Carnegie-Mellon University. Berg was also Provost, President and institute professor at Rensselaer Polytechnic Institute.

  • Dr. James M. Tien, member of NAE and Dean of the University of Miami College of Engineering. He has held leadership positions at Bell Telephone Laboratories, at the Rand Corporation and at Rensselaer Polytechnic Institute, where he served as faculty member and Acting Dean of Engineering.

  • Dr. Donna E. Shalala, President of the University of Miami and member of IOM. She served as Chancellor of the University of Wisconsin-Madison and as President of Hunter College of the City University of New York and is the longest serving U.S. Secretary for Health and Human Services in American history.

  • Dr. Charles M. Vest, President of NAE, and Presi
    '/>"/>

Contact: Marie Guma-Diaz
m.gumadiaz@umiami.edu
305-284-1601
University of Miami
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal
2. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
3. Entrust Continues Leadership by Adding Support for Next-generation E-Passports
4. IEEE-USA innovation forum will help prepare US tech leaders to prosper in a global marketplace
5. Stronger EPA leadership needed to improve water quality in Mississippi River
6. Toxic releases down from North American industry leaders, increasing from other facilities
7. Abel to receive posthumous Ocean and Coastal Leadership award
8. UCSD bioengineering grad student wins leadership award
9. Too few women scientists achieving academic leadership positions
10. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
11. 19 researchers selected as 2008 Leopold Leadership Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... occur in the body, stem cells in the ... differentiating into mature immune cells that can fight ... deplete these cell populations, potentially leading to the ... Now, a team of researchers led by biologists ... found that, in mouse models, the molecule microRNA-146a ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... The Potato Genome Sequencing Consortium (PGSC), an international ... countries, has released a draft sequence of the potato ... Richard Veilleux, professor of horticulture in the College ... a unique phureja type of potato variety that accelerated ...
... could enhance plants, seed oil content for food and ... Science under an exclusive commercial agreement with Michigan State ... that regulates oil accumulation in plant seed was licensed ... technology transfer office. The gene is a transcription factor ...
... German . , Necessity is the mother ... harsh conditions of snow cover. This remarkable newly-acquired behaviour was ... in Seewiesen and their colleagues in a cave in Hungary. ... it and showed little or no interest in flying into ...
Cached Biology News:Draft potato genome based on unique potato variety 2MSU licenses plant oil enhancement technology to BASF Plant Science 2Great tits eat bats in times of need 2
(Date:5/21/2013)... Wisc. (PRWEB) May 21, 2013 ... parts distributor , will be exhibiting for the ... Advancement of Medical Instrumentation (AAMI) 2013 Conference and ... purchase, support, distribute, and manufacture healthcare technologies. This ... in Long Beach, California. , The three-day ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... 4, 2011 Palatin Technologies, Inc. (NYSE Amex: ... Phase 1 clinical trial of AZD2820, a subcutaneously-administered peptide ... therapy for the treatment of obesity. AZD2820 is a ... program with Palatin Technologies. Obesity is a ...
... SynCo Bio Partners B.V., one of the leading ... filling facility is again fully operational and SynCo has produced ... after the expansion of its Class A zone.   ... important milestone in SynCo,s strategy in supporting its clients with ...
...   Creabilis SA, a clinical stage ... and pain, announces today that Dr David Roblin has been ... extensive experience in the pharmaceutical industry in a career spanning ... several drugs to the market. He has held leadership roles ...
Cached Biology Technology:Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca 2Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca 3SynCo Bio Partners Expands the Class A Zone in its Aseptic Filling Facility 2Creabilis Appoints Dr David Roblin as Chief Medical Officer 2Creabilis Appoints Dr David Roblin as Chief Medical Officer 3